A potentially life-saving cancer medicine that patients must self-fund at a cost of more than 200-thousand dollars, is being made available on prescription. The move brings down the cost to less than forty-dollars, every three weeks. It's one of five new drugs added to the Pharmaceutical Benefits Scheme
Share
